Genentech - A Member of the Roche Group

What's New @Asco

Load More  

The Next Generation

Biology has moved from a descriptive science to one that allows scientists to engineer potential new types of therapeutic antibodies. What's next?

Big Data

Everyone is talking about the medical implications of big data. Read 5 things big data can and can't do in cancer research.

Discover the Data

Read our press releases, explore our data, and learn about what we're presenting at the 49th meeting of the American Society of Clinical Oncology.

Unlocking a Paradox

Genentech scientists came across a boggling observation. Take a look at a discovery that may have important implications for personalized medicine.

The Patient Voice

This year at ASCO, we’ll see data from clinical trials on the most cutting-edge approaches to cancer treatment. Beyond the numbers, how are patients actually feeling?

Resistance is Not Futile

There is tremendous hope to transform cancer into a manageable disease with combinations of targeted medicines.

Building A Better Booth

The relationship between companies and researchers is critical as both play an important role in bringing new medicines to people with cancer.

Lung Cancer Project

Conscious and subconscious perceptions influence the way we view race, wealth and gender. But what about cancer?

The Antibodies

The science behind our medicines is complex. We've brought along some friends to help us explain it.

Scientific Compassion

Dr. Hal Barron, talks about Expanded Access Programs (EAP), compassionate use, and how we address access to unapproved medicines.

Immunotherapy Now

Scientists first considered the prospect of harnessing the body's own immune system to fight cancer more than 100 years ago.

Calling Citizen Scientists

Stay sharp during downtime at ASCO 2013. Download our iPad app that integrates science and technology into a fun and smart game.

What is Your #ASCOIQ?

Test your knowledge of conference jargon and oncology terminology with our flashcards.

A Patient & A Leader

Sandra Horning, Global Head of Oncology, shares her experiences attending ASCO over the last 34 years, and fighting cancer in multiple ways.

Load More  

Our Media Team at ASCO